Podcast
BioVenture VoiCes with Chris Garabedian
Hosted by BiotechTV · EN
Hosted by Chris Garabedian, meet the leading Voices in the BioVenture community and hear their insights and perspectives on the challenges and successes with VC investing.
10episodes
Episodes
Newest firstAll episodes
Episode 41: Forbion's Nanna Lüneborg
2w ago01:02:00Tap to summarizeNanna Luneborg discusses hear career and joining Forbion. She describes the firm's investment approach, and her experience with everything from seed, to private, and to public investing in life sciences. Plus, thoughts on China and AI in biotech.
Transcribe →
Episode 40: GV's Krishna Yeshwant
4w ago01:19:12Tap to summarizeHe describes his well-rounded background of studying and working in both software in Silicon Valley and Medicine in Boston, and the start of GV. He describes a conservative start to investing at GV, but also today how Alphabet's scale and cash gives them the ability to ride cycles and make concentrated bets on companies the team has conviction on.
Transcribe →
Episode 39: SV Health Investors' Kate Bingham
May 401:12:46Tap to summarizeKate Bingham describes her early life and a serendipitous opportunity to work at Vertex in the early 1990's. She then discusses joining SV Health and describes its investment approaches, the Dementia Discovery Fund, being on the UK's Vaccine Taskforce during Covid, and more.
Transcribe →
Episode 38: Deerfield Management's Jason Fuller
Apr 2001:05:48Tap to summarizeHe discusses his education and joining the Langer Lab at MIT, early experiences in venture, including at Third Rock and NEA, and gaining operational experience at Jounce before joining Deerfield. Plus, areas that interest him today and how he thinks about AI.
Transcribe →
Episode 37: SR One's Simeon George
Mar 2301:06:16Tap to summarizeSimeon George discusses his early days at SR One while it was part of GSK, and the transition to making the firm independent in 2020. Plus, the importance of peer-to-peer collaboration, and his how he thinks about investing in different indications and modalities.
Transcribe →
Episode 36: Sofinnova Invetments' Jim Healy
Mar 901:01:37Tap to summarizeHe discusses learnings from his decades in venture at Sofinnova Investments including 'products vs platform', therapeutics areas of interest, modalities, and how he utilizes board seats and thinks about management teams.
Transcribe →
Episode 35: INITIATE Ventures' Jessica Owens
Feb 2301:09:09Tap to summarizeJessica Owens discusses the many experiences she has had in her career, including working on the venture side at Kleiner Perkins and Versant Ventures and on the operating side at Genomic Health and Grail. She highlights the value of VCs being able to understand how operators like CEOs think, and describes the type of investing INITIATE focuses on.
Transcribe →
Episode 34: General Atlantic's Brett Zbar
Feb 901:07:01Tap to summarizeBrett Zbar describes his early career, including working at Aisling Capital and Foresight Capital, and now managing the healthcare strategy at General Atlantic. He describes how he sees the difference between private equity and venture capital, and discusses which themes in biotech and healthcare appeal to him today.
Transcribe →
Episode 33: Pappas Capital's Art Pappas
Jan 2600:58:12Tap to summarizeArt Pappas describes his early career, which involved numerous overseas posts for large companies, and how it let him to eventually found Pappas Capital. He discusses the various ways the firm invests, and how having corporates partners as LPs and co-investors has been a recipe for success.
Transcribe →
Episode 32: ARCH Venture Partners' Bob Nelsen
Jan 1101:15:05Tap to summarizeWhile describing his early life in Washington and formative years at the University of Chicago that led to the founding of ARCH, he shares his thoughts on leadership, risk taking, changes he thinks are need to keep the United States competitive in life sciences, and his belief in AI's promise to transform our industry.
Transcribe →